3-iodobenzylguanidine has been researched along with iopamidol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amanuma, M; Endo, K; Higuchi, T; Nakano, S; Oriuchi, N; Taketomi-Takahashi, A; Tsushima, Y | 1 |
| Caoili, EM; Cohan, RH; Davenport, MS; Patel, J | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and iopamidol
| Article | Year |
|---|---|
Hypertensive crisis due to contrast-enhanced computed tomography in a patient with malignant pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Contrast Media; Humans; Hypertensive Encephalopathy; Iopamidol; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Can established CT attenuation and washout criteria for adrenal adenoma accurately exclude pheochromocytoma?
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Diagnosis, Differential; Female; Humans; Iohexol; Iopamidol; Male; Middle Aged; Pheochromocytoma; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2013 |